CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Postprandial glucose

Glycemic & MetabolicLab test / biomarkerriskmodifiable
19
evidence score

Also known as: post-load glucose, postload glucose, postprandial glycaemia

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 6meta-analyses: 6trials: 7genetic: 0MR bonus:

References (3)

1 meta-analyses / systematic reviews

Clinical trials (4)

NCTTitleStatusTypeInterventions
NCT05766735Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle ModificationRECRUITINGINTERVENTIONALRoutine Care + Glycemic Excursion Minimization (RC+GEM), Routine Care (RC)
NCT02773381A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 DiabetesCOMPLETEDINTERVENTIONALsemaglutide, placebo
NCT02585427Effects of Co-ingesting a Low/High GI Meal With Different Fat Saturation on Postprandial Glucose, Insulin, and Triacylglycerol Responses in Healthy ParticipantsCOMPLETEDINTERVENTIONALlow glycemic index rice, high glycemic index rice, butter, olive oil and grapeseed oil
NCT01248364An Open-label, Phase II Study to Determine Acute (After the First Dose Administration) and Chronic (After 28 Days of Treatment) Effects of the Sodium-glucose Co-transporter-2 (SGLT-2) Inhibitor Empagliflozin (BI 10773) (25 mg Once Daily) on Pre and Postprandial Glucose Homeostasis in Patients With IGT and, Type 2 Diabetes Mellitus and Healthy SubjectsCOMPLETEDINTERVENTIONALBI 10773

Genetic associations (0)

None linked.